netFormulary NHS
Birmingham, Sandwell, Solihull and environs APC Formulary
Maintained by Midlands and Lancashire Commissioning Support Unit
 Search
 Formulary Chapter 3: Respiratory system - Full Section
Notes:

Prescribing inhalers

• Prescribe by brand or branded-generic name to ensure patients receive the device they are used to.
• Check licensed indication (differences among brands).
• Be aware of differences in excipients among the different brands.

 Useful Links
Numbers in brackets indicate counts of (Formulary items, Non Formulary items)
03.01 Bronchodilators (0,0)
Asthma (0,0)
Chronic obstructive pulmonary disease (0,0)
Croup (0,0)
03.01.01 Adrenoceptor agonists (0,0)
03.01.01.01 Selective Beta2 agonists (7,4)
Short-acting beta2 agonists (0,0)
Long-acting beta2 agonists (0,0)
03.01.01.02 Other adrenoceptor agonists (0,2)
03.01.02 Antimuscarinic bronchodilators (5,2)
Short Acting Anti-muscarinic Bronchodilators (0,0)
Long Acting Anti-muscarinic Bronchodilators (0,0)
03.01.03 Theophylline (3,2)
03.01.04 Compound bronchodilator preparations (4,2)
03.01.05 Peak flow meters, inhaler devices and nebulisers (0,1)
Peak flow meters (2,0)
Drug delivery devices (2,0)
Nebuliser Diluent (1,0)
03.02 Corticosteroids (11,8)
03.02.01 Inhaled Corticosteroids (0,0)
03.02.02 Combination products (ICS+LABA) for asthma (0,0)
Low dose (0,0)
Moderate dose (0,0)
High dose (0,0)
03.02.03 Combination products (ICS+LABA) for COPD (2,0)
03.03 Cromoglicate, related therapy and leukotriene receptor antagonists (0,0)
03.03.01 Cromoglicate and related therapy (0,4)
Related therapy (0,0)
03.03.02 Leukotriene receptor antagonists (1,1)
03.03.03 Phosphodiesterase type-4 inhibitors (1,0)
03.04 Antihistamines, hyposensitisation, and allergic emergencies (0,0)
03.04.01 Antihistamines (0,0)
Non-sedating antihistamines (3,6)
Sedating antihistamines (4,3)
03.04.02 Allergen Immunotherapy (4,0)
Omalizumab (0,0)
03.04.03 Allergic emergencies (0,0)
Anaphylaxis (3,2)
Angioedema (4,0)
Intramuscular adrenaline (epinephrine) (0,0)
Intravenous adrenaline (epinephrine) (0,1)
Self-administration of adrenaline (epinephrine) (0,0)
03.05 Respiratory stimulants and pulmonary surfactants (0,0)
03.05.01 Respiratory stimulants (2,0)
03.05.02 Pulmonary surfactants (1,1)
03.06 Oxygen (1,0)
Long-term oxygen therapy (0,0)
Short burst oxygen therpary (0,0)
Ambulatory oxygen therapy (0,0)
Oxygen therapy equipment (0,0)
Arrangements for supplying oxygen (0,0)
03.07 Mucolytics (6,1)
Dornase alfa (1,0)
Hypertonic Sodium Chloride (2,3)
03.08 Aromatic inhalations (0,3)
03.09 Cough preparations (0,0)
03.09.01 Cough suppressants (1,6)
Palliative care (1,1)
03.09.02 Expectorant and demulcent cough preparations (2,1)
03.10 Systemic nasal decongestants (1,0)
03.11 Antifibrotics (2,0)
03.12 Other drugs for Interstitial lung disease (idiopathic pulmonary fibrosis) (3,0)
03.13 Nebulised antibiotics for cystic fibrosis (8,0)
03.14 Monoclonal Antibody (4,0)
03.15 Cystic Fibrosis (1,0)
netFormulary